Ameritas Advisory Services LLC Has $107,000 Position in iShares Biotechnology ETF $IBB

Ameritas Advisory Services LLC lessened its position in iShares Biotechnology ETF (NASDAQ:IBB) by 84.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 745 shares of the financial services provider’s stock after selling 4,142 shares during the period. Ameritas Advisory Services LLC’s holdings in iShares Biotechnology ETF were worth $107,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Darwin Wealth Management LLC acquired a new position in iShares Biotechnology ETF during the second quarter worth approximately $25,000. Financial Gravity Companies Inc. bought a new position in shares of iShares Biotechnology ETF during the 2nd quarter worth approximately $29,000. Ashton Thomas Securities LLC bought a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth approximately $36,000. Parkside Financial Bank & Trust increased its holdings in shares of iShares Biotechnology ETF by 48.6% during the 3rd quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock worth $38,000 after acquiring an additional 87 shares during the last quarter. Finally, Princeton Global Asset Management LLC raised its stake in iShares Biotechnology ETF by 375.0% in the 3rd quarter. Princeton Global Asset Management LLC now owns 380 shares of the financial services provider’s stock valued at $55,000 after acquiring an additional 300 shares during the period. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Up 0.4%

Shares of iShares Biotechnology ETF stock opened at $174.76 on Thursday. The business has a fifty day simple moving average of $171.99 and a two-hundred day simple moving average of $158.26. iShares Biotechnology ETF has a 1 year low of $107.43 and a 1 year high of $179.64.

iShares Biotechnology ETF Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, December 19th. Stockholders of record on Tuesday, December 16th were paid a dividend of $0.1831 per share. The ex-dividend date was Tuesday, December 16th. This represents a $0.73 dividend on an annualized basis and a dividend yield of 0.4%. This is a boost from iShares Biotechnology ETF’s previous quarterly dividend of $0.08.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.